CIK: 1257809 - Address: C/O Bridgebio Pharma, Inc., 3160 Porter Dr., Suite 250, Palo Alto, CA 94304
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/28/23 16:00
12/26/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsMcCormick FrankCADS-4,20642.060-100-81,100I
11/17/20 16:05
11/13/20
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsMcCormick FrankCAOCB of OnS-4,27642.760-100-81,200D
12/31/19 16:05
12/27/19
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsMcCormick FrankCAOCB of OnS.m-3,75537.550-100-71,262D
7/3/19 16:14
7/1/19
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsMcCormick FrankCAOCB of OnM.d00.0001,361New1,361D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact